企業プロフィール

Stryker 株価・ニュース・カタリスト

ティッカー:
SYK
取引所:
NYSE
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

331.68 USD (-2.22%)

終値

最終更新: 2026年8月17日

112B USD

時価総額

株価変動の要因

As of Aug 17, 2026, SYK closed down 2.22% at $331.68. No new same-company headline was identified in the current news window.

企業概要

Global MedTech Leader

Stryker is a global medical technology company offering products and services across MedSurg, Neurotechnology, and Orthopaedics. Its scale, global customer base, and product breadth make it one of the largest diversified medtech companies, with products that support surgical procedures, hospital workflows, orthopedic reconstruction, and neurotechnology care.

MedSurg and Neurotechnology Engine

MedSurg and Neurotechnology is Stryker's largest segment, generating $3.6 billion in second-quarter 2026 net sales. Growth was driven mainly by unit volume, showing continued demand across the company's procedural and hospital-facing technology portfolio.

Orthopaedics Franchise

Orthopaedics remains a major growth pillar, with $3.0 billion in second-quarter sales and strong organic growth. Stryker also reorganized elements of its orthopaedic instruments, neuro cranial, spine enabling technologies, and related portfolios to better align with internal reporting and business management.

Operational Resilience

The quarter also reflected recovery from a cyber incident reported earlier in 2026. Despite that disruption, Stryker delivered strong sales, EPS, and operating cash flow growth. This supports the company's positioning as a resilient medtech operator with a steady cadence of innovation and disciplined execution.

今後のカタリスト

    最近のニュース

    1. 01
    2. 02
    3. 03
    4. 04
    5. 05

    類似銘柄

    事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。